Trial: Metformin, ivermectin, fluvoxamine don't prevent severe COVID - CIDRAP

A secondary analysis finds that metformin may hold some promise.

A phase 3 randomized, controlled trial published today in the New England Journal of Medicine shows that three drugs repurposed for the treatment of COVID-19metformin, ivermectin, and fluvoxaminedidn… [+6221 chars]

full article...